Evidence map›Paper›PMID 38727230›Full record

ArticleMicrobiology spectrum2024

Emergence of carbapenem-resistant

Joaquim Viñes, Carlos Lopera, Andrea Vergara, Ignasi Roca, Jordi Vila, Climent Casals-Pascual, José Antonio Martínez, Carolina García-Vidal, Alex Soriano, Cristina Pitart

Abstract readCase Reports
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Emergence of KPC-producingAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joaquim ViñesServei de Microbiologia i Parasitologia-CDB, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0003-0709-5236
Carlos LoperaDepartament de Malalties Infeccioses, Hospital Clínic de Barcelona, Barcelona, Spain.
Andrea VergaraServei de Microbiologia i Parasitologia-CDB, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-5046-4490
Ignasi RocaServei de Microbiologia i Parasitologia-CDB, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-1800-1576
Jordi VilaServei de Microbiologia i Parasitologia-CDB, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-8025-3926
Climent Casals-PascualServei de Microbiologia i Parasitologia-CDB, Hospital Clínic de Barcelona, Barcelona, Spain.
José Antonio MartínezDepartament de Malalties Infeccioses, Hospital Clínic de Barcelona, Barcelona, Spain.
Carolina García-VidalDepartament de Malalties Infeccioses, Hospital Clínic de Barcelona, Barcelona, Spain.ORCID 0000-0002-8915-0683
Alex SorianoDepartament de Malalties Infeccioses, Hospital Clínic de Barcelona, Barcelona, Spain.
Cristina PitartServei de Microbiologia i Parasitologia-CDB, Hospital Clínic de Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe four cases of a novel carbapenem-resistant IMPORTANCE: This is the first documented case of a

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCarbapenemsDrug Resistance, Multiple, BacterialPseudomonas aeruginosaPseudomonas InfectionsAdultBacterial ProteinsFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedPeruPlasmidsSpainAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase KPC-2beta-LactamasesCarbapenemscarbapenemasecarbapenem-resistantIlluminaIMP-16KPC-2KPC-35leukemiananoporePseudomonas aeruginosaST179

Identifiers

PMID38727230
PMCPMC11237478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.